Applied BioCodeTPE:6598 74 Gross Margin % is 41.68% as of Dec. 2025, which is 27% below its 10-year median of 57.04. GuruFocus rates TPE:6598 with a GF Score™ of 74/100 and a GF Value™ of NT$23.33 (Fairly Valued). The stock has 6 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Applied BioCode ranks better than 55.4% on this metric.
Applied BioCode Corp gross margin has been in long-term decline. The average rate of decline per year is -1.9%.
The historical rank and industry rank for Applied BioCode's Gross Margin % or its related term are showing as below:
TPE:6598'
s Gross Margin % Range Over the Past 10 Years
Min: 33.32 Med: 57.04 Max: 68.01
Current: 54.9
During the past 13 years, the highestGross Margin % of Applied BioCode was 68.01%. The lowest was 33.32%. And the median was 57.04%.
TPE:6598's Gross Margin % is ranked better than 55.4% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 51.94
vs TPE:6598: 54.90
Applied BioCode had a gross margin of 41.68% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Applied BioCode was -1.90% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Applied BioCode had a gross margin of 41.68% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Applied BioCode Gross Margin % Related Terms
Applied BioCode Gross Margin % Historical Data
* Premium members only.
The historical data trend for Applied BioCode's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6598 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Applied BioCode's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Applied BioCode Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Applied BioCode's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Applied BioCode's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Applied BioCode (TPE:6598) has a Gross Margin % of 41.68% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Applied BioCode and its competitors. This is 27% below median its historical median of 57.04. Over the past decade, Applied BioCode's Gross Margin % has ranged from 33.32 to 68.01. According to the industry distribution chart, Applied BioCode ranks #359 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 44.6%.
Is Applied BioCode's Gross Margin % too high?
Applied BioCode's current Gross Margin % of 41.68% is 27% below median its 10-year median of 57.04. Over the past 10 years, this metric has ranged from a low of 33.32 to a high of 68.01. The Medical Devices & Instruments industry median Gross Margin % is 51.94. Applied BioCode's value of 41.68% is 19.8% below this industry median. Based on the distribution chart, Applied BioCode ranks #359 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Applied BioCode has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Applied BioCode's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Applied BioCode ranks #359 out of 805 companies for Gross Margin %. This puts Applied BioCode in the upper half of its industry. The industry median Gross Margin % is 51.94. Applied BioCode's value of 41.68% is 19.8% below this benchmark. Historically, Applied BioCode's own Gross Margin % has ranged from 33.32 to 68.01 over the past decade. While the company's 10-year median is 57.04 vs. the industry median of 51.94, Applied BioCode has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Applied BioCode's current Gross Margin % of 41.68% is 19.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Applied BioCode and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Applied BioCode's current Gross Margin % is 41.68%, which is 27% below median its own 10-year median of 57.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied BioCode stock overvalued right now?
Based on GuruFocus' analysis, Applied BioCode (TPE:6598) is currently considered Fairly Valued. The stock's GF Value™ is NT$23.33, compared to a current price of NT$22.85 — trading 2.1% below its estimated fair value. The current Gross Margin % is 41.68%, which is 27% below median its 10-year median of 57.04 and 19.8% below the Medical Devices & Instruments industry median of 51.94. Applied BioCode's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Applied BioCode (TPE:6598), the current Gross Margin % is 41.68% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Applied BioCode (TPE:6598) Overvalued in 2026?
Based on GuruFocus' analysis, Applied BioCode stock appears to be undervalued.
The current stock price of NT$22.85 is trading 2.1% below its estimated GF Value™ of NT$23.33.
GuruFocus considers Applied BioCode to be Fairly Valued.
Key valuation signals for TPE:6598:
Gross Margin %: 41.68% (27% below median its 10-year median of 57.04)
GF Value™: NT$23.33 vs. price of NT$22.85 (2.1% below fair value)
Industry Position: 19.8% below the Medical Devices & Instruments median (#359 of 805)
No single metric tells the full story. See the TPE:6598 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.
74GF Score
Get the complete analysis for TPE:6598
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6598 has been successfully added to your 
